thesisgsk investor presentation 2022Share on FacebookShare on Twitter490IMAGESGSK delivers strong Q1 2022 sales of £9.8 billion, +32% AER, +32% CERGSK delivers strong 2022 performance with full year sales of £29.3GlaxoSmithKline (GSK) Investor PresentationGSK delivers strong Q2 2022 sales of £6.9 billion +19% at AER, +13% atGlaxoSmithKline plc 2022 Q1GlaxoSmithKline plc 2022 Q1
IMAGES